, December 07, 2017 ) North America RNA Analysis Market
size was around USD 660 million in 2016. It is expected to grow at a CAGR of 13.7% to reach USD 1.26 billion by 2021. It captures 35% of the global market.The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines.
However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyse enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent.
Get Comprehensive Report @ http://www.marketdataforecast.com/market-reports/north-america-rna-analysis-market-4542/
North America RNA Analysis Market segmentation by end user, type, and application. By end user the market is segmented into Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Diagnostic Centres. By type the market is segmented into Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, and RNAI Gene Silencing. Microarrays are further sub-segmented into Reagents, Instruments and Software. Polymerase Chain Reaction (PCR) is further sub-segmented into Reagents, Instruments and Software. Sequencing Technologies are further sub-segmented into Sanger Sequencing (Reagents, Instruments and Software), and Next Generation Sequencing (NGS) (Reagents, Instruments and Software). RNAI Gene Silencing is further sub-segmented into Reagents, Instruments and Software. By application the market is segmented into Clinical Diagnosis, Drug Discovery, and Toxic genomics. North America RNA Analysis Market geographical segmentation by US and Canada. North America accounts for the largest share of the market.
Download Free Sample Report @ http://www.marketdataforecast.com/market-reports/north-america-rna-analysis-market-4542/request-sample
The major RNA Analysis Market leaders are Illumina Inc. (U.S.), Qiagen N.V. (Germany), Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), and Thermofisher Scientific Inc. (U.S.).
1) By End User: Introduction, Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers
2) By Type: Introduction, Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, Next Generation Sequencing (NGS), RNAI Gene Silencing
3) By Application: Introduction, Clinical Diagnosis, Drug Discovery, Toxicogenomics
4) By Geography: Introduction, United States, Canada and Mexico
Inquire before buying @ http://www.marketdataforecast.com/market-reports/north-america-rna-analysis-market-4542/inquire
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
For more information, kindly visit, www.marketdataforecast.com
Market Data Forecast